Psilocybin mushrooms (“magic mushrooms”) are physiologically one of the safer recreational drugs, but they carry real risks, particularly psychological ones. The most common negative effects during a session are headache (affecting about 24% of users), nausea (22%), and dizziness or fatigue (around 6% each). The bigger dangers tend to involve mental health: panic, paranoia, and in rare cases, psychotic episodes that can persist beyond the trip itself.
Physical Side Effects During a Trip
Nausea is the most well-known physical complaint, affecting roughly one in five users. Some people vomit, especially early in the experience as the body digests the raw mushroom material. Headache is actually slightly more common than nausea in clinical settings. Dizziness, shivering, and abdominal pain round out the typical list of physical symptoms, though some researchers believe a portion of these are psychosomatic, driven by the altered mental state rather than direct drug toxicity.
Psilocybin also temporarily raises blood pressure and heart rate. Systolic blood pressure can increase by about 20 points and diastolic by about 15, while heart rate may climb toward 100 beats per minute. For a healthy person, this is generally insignificant. For someone with coronary artery disease or elevated stroke risk, those temporary spikes could be dangerous.
Anxiety, Panic, and “Bad Trips”
The most frequently reported negative effects are psychological. In one study of people who sought emergency treatment after using magic mushrooms, 68% reported anxiety or panic and 68% reported paranoia or suspiciousness. Fear, disorientation, grief, and a sense of losing control are all common features of a difficult experience. These reactions can happen even at moderate doses, and they’re not limited to first-time users.
Setting and mental state going into the experience matter enormously. Using mushrooms in an unfamiliar or chaotic environment, while already feeling anxious, or at a higher dose than expected all increase the likelihood of a distressing trip. In clinical trials, where participants are screened, prepared, and supervised, bad reactions still occur but are far less severe. Emergency room visits related to magic mushrooms do happen but are typically short, with most people discharged quickly once the drug wears off.
Risk of Psychosis
The most serious psychological risk is a psychotic episode, which can involve delusions, paranoia, catatonia, or suicidal thoughts that persist after the drug has left the body. Published case reports reveal a consistent pattern in who this affects: people with a personal or family history of psychiatric disorders, particularly schizophrenia, bipolar disorder, or psychotic features. A history of depression, anxiety, PTSD, or personality disorder traits also appears as a predisposing factor across multiple documented cases. Concurrent cannabis use shows up repeatedly as an additional risk factor.
One documented case involved a man with a history of depression and personality disorder traits who developed psychotic and catatonic symptoms after several months of heavy psilocybin use. His case illustrates that the risk isn’t confined to people with obvious psychotic histories. Even relatively common conditions like depression and anxiety may increase vulnerability, especially with repeated or heavy use.
Lingering Visual Disturbances
Some users experience visual effects that persist after the trip ends, a phenomenon sometimes called Hallucinogen Persisting Perception Disorder (HPPD). These can include halos around objects, visual snow, or brief flashes of color. In one study, about 32% of participants reported at least one HPPD-related visual effect four weeks after use. That number sounds alarming, but context matters: fewer than 1% of the total sample found these effects distressing. For the vast majority, the lingering visual quirks were mild and didn’t interfere with daily life. Across multiple studies, the estimated rate of clinically significant HPPD among psychedelic users overall falls below 1%.
Interactions With Antidepressants
If you take an SSRI or similar antidepressant, combining it with psilocybin creates a complicated interaction. These medications work on the same serotonin system that psilocybin targets. Chronic antidepressant use reduces both the number and sensitivity of serotonin receptors in the brain, which is exactly where psilocybin needs to act. The practical result: about half of people on antidepressants report a weakened or virtually eliminated psychedelic experience. In one early study, 88% of patients on antidepressants for more than three weeks reported a dramatically reduced response to psychedelics.
Clinical trials typically require participants to stop antidepressants at least two weeks before receiving psilocybin. This isn’t just about effectiveness. The safety profile of combining these substances hasn’t been fully established, and the theoretical concern of serotonin syndrome (a dangerous excess of serotonin activity) remains. Stopping antidepressants abruptly carries its own risks, so this creates a real practical dilemma for anyone considering psilocybin who is currently medicated.
Cognitive Effects
Research on long-term cognitive impact is still limited. A systematic review found that cognitive flexibility and creative thinking initially declined after psilocybin use but showed potential improvement over time. There is no strong evidence of lasting brain damage or permanent cognitive deficits. Psilocybin has not been linked to organ damage or neurological deterioration, and it carries no established addiction potential.
The Danger of Misidentification
One risk that has nothing to do with psilocybin itself is picking the wrong mushroom. Wild mushroom foraging is genuinely dangerous because several highly toxic species can resemble psilocybin-containing ones. Mushrooms in the Amanita genus, for instance, contain toxins that can cause liver failure and death. Other poisonous varieties contain compounds that cause kidney damage, paralysis, or seizures. Unlike psilocybin, which is extremely difficult to fatally overdose on (the estimated lethal dose would require consuming roughly 10 kilograms of fresh mushrooms, an amount your body would reject through vomiting long before absorbing), a small serving of the wrong species can be deadly.
Overdose and Lethal Risk
Psilocybin itself has an extraordinarily wide safety margin. The lethal dose is estimated at roughly 1,000 times the threshold active dose, making a fatal overdose from the drug alone essentially impractical. Only three deaths in the medical literature have been attributed directly to magic mushroom toxicity. The real overdose danger is psychological, not physiological. Taking too much can produce intense terror, confusion, and dangerous behavior (running into traffic, for example) rather than organ failure or respiratory depression.
Pregnancy and Breastfeeding
There is almost no research on psilocybin during pregnancy or breastfeeding. No human studies have examined whether magic mushrooms affect fertility, increase miscarriage risk, cause birth defects, or lead to developmental problems in children. A single animal study showed no increased chance of birth defects, but one animal study is a thin basis for any conclusion. It is also unknown whether psilocybin passes into breast milk or what effect it might have on a nursing infant. The honest answer is that the risks in pregnancy are simply unknown.